Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - digoxin, quantity: 250 microgram - tablet, uncoated - excipient ingredients: magnesium stearate; rice starch; lactose monohydrate; oxidised maize starch; hydrolysed maize starch - congestive heart failure - sigmaxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. sigmaxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because sigmaxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - sigmaxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - digoxin, quantity: 0.0625 microgram - tablet, uncoated - excipient ingredients: lactose monohydrate; rice starch; magnesium stearate; hydrolysed maize starch; povidone; indigo carmine; oxidised maize starch - congestive heart failure - sigmaxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. sigmaxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because sigmaxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - sigmaxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - digoxin, quantity: 250 microgram - tablet, uncoated - excipient ingredients: oxidised maize starch; maize starch; magnesium stearate; lactose monohydrate; rice starch - indications as at 26 july 2000 : congestive heart failure - lanoxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. lanoxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because lanoxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - lanoxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

renata (uk) limited - hydrocortisone - tablet - 10 milligram(s) - glucocorticoids; hydrocortisone

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

renata (uk) limited - hydrocortisone - tablet - 20 milligram(s) - glucocorticoids; hydrocortisone

Մալթա - անգլերեն - Medicines Authority

renata pharmaceuticals (ireland) limited 13-18 city quay, dublin , dublin, d02ed70 , ireland - film-coated tablet - apixaban 2.5 mg - antithrombotic agents

Մալթա - անգլերեն - Medicines Authority

renata pharmaceuticals (ireland) limited 13-18 city quay, dublin , dublin, d02ed70 , ireland - film-coated tablet - apixaban 5 mg - antithrombotic agents

Մալթա - անգլերեն - Medicines Authority

renata pharmaceuticals (ireland) limited 13-18 city quay, dublin , dublin, d02ed70 , ireland - film-coated tablet - naratriptan 2.5 mg - analgesics

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

renata pharmaceuticals (ireland) limited - hydrocortisone - tablet - hydrocortisone

Մալթա - անգլերեն - Medicines Authority

renata pharmaceuticals (ireland) limited 13-18 city quay, dublin , dublin, d02ed70 , ireland - film-coated tablet - rivaroxaban 15 mg - antithrombotic agents